Coinbase 上線波卡生態智能合約平臺 Clover Finance 代幣 CLV
鏈聞消息，Coinbase 正式上線波卡生態智能合約平臺 Clover Finance 代幣 CLV，Coinbase.com、Coinbase Android 和 iOS 應用程序用戶（除紐約州外）現在可以交易、兌換、發送、接收或存儲 CLV。Coinbase Pro 也已可交易 CLV ，不過目前僅支持 ERC-20 標準的 CLV 。
鏈聞注，Clover Finance 是基於 Substrate 的 Polkadot 平行鏈，致力於提供易於使用的區塊鏈基礎架構、創建一站式綜合基礎架構平臺，以降低開發人員的門檻和成本併爲開發人員帶來豐厚的回報。
Clover Finance (CLV) Launches on Coinbase Pro
Support for Clover Finance (CLV) will only be available in the United States with the exception of New York residents.
Clover Finance (CLV), a foundational layer for cross-chain compatibility, announced the inbound transfer of ERC20-based CLV on Coinbase Pro. Support for Clover Finance (CLV) will only be available in the United States with the exception of New York residents.
Notably, Coinbase announced that trading will commence immediately only if the conditions are met. “Once sufficient supply of CLV is established on the platform, trading on our CLV-USD, CLV-EUR, CLV-GBP, CLV-USDT order books will launch in three phases, post-only, limit-only, and full trading. If at any point one of the new order books does not meet our assessment for a healthy and orderly market, we may keep the book in one state for a longer period of time or suspend trading as per our Trading Rules,” Coinbase noted in a Medium blog post.
Subsequent updates are expected from the Coinbase official’s Twitter account. Notably, CLV has not been made available on the consumer mobile application or via the Coinbase.com platform. However, Coinbase indicated the listing may change depending on the demand and also the liquidity level. According to the crypto exchange, it deploys strict listing rules to protect its customers from unhealthy market players. Furthermore, the cryptocurrency industry is maturing and not fully regulated by various jurisdictions.
Ranked position 2571 according to Coinmarketcap metrics, CLV was trading around $0.765 at the time of reporting, down 76.13% in the past 24 hours. Notably, the asset has dropped from trading around $42.21 at the end of April to below a dollar.
Clover Finance (CLV) and Crypto Market
Clover Finance (CLV) is unique due to the fact that it utilizes BIP-Schnorr compatible threshold signatures to enable meaningful cross-chain communication between networks. As a result, developers can interact seamlessly between one blockchain to another at a minimal cost and fast speed.
The CLV token has several use cases in the Clover Finance ecosystem. First, it is used as the governance token to enable the community to vote on the system upgrades. Secondly, CLV is used to pay for transactional fees on the platform.
According to the Clover finance Litepaper, the platform provides a perfect gateway to a decentralized financial ecosystem for everyone including those new to the industry.
Notably, Clover Finance has an inbuilt EVM-compatible infrastructure to help developers migrate existing decentralized applications to their desired and supported blockchains.
As a result, the platform gets a competitive edge against other cross-chain players.
Although there is a huge demand for a decentralized financial ecosystem, those providing a linkage between the real world and the digital world at an affordable price win the market.
Clover Health today announces that Joe Wagner, Chief Financial Officer, will leave the company on August 13th
Lee Shapiro, Clover Audit Committee Chair, will lead the search for the next Clover CFO.
Mark Herbers of AlixPartners, LLP will act as Interim CFO while the search is conducted.
NASHVILLE, Tenn., July 15, 2021 (GLOBE NEWSWIRE) – Clover Health (Nasdaq: CLOV) (“Clover”) today announced that Joseph Wagner, its Chief Financial Officer, will be leaving the company on August 13th for personal reasons described below. Effective upon Mr. Wagner’s departure, Mark Herbers of leading global consulting firm AlixPartners, LLP will serve as Interim Chief Financial Officer until a permanent CFO is hired. Mr. Herbers has served as CFO for a number of public and private healthcare organizations and has 20 years of experience in the sector.
Mr. Lee A. Shapiro, a member of the Clover Board of Directors and Chair of its Audit Committee, will lead the search committee that will oversee the process to replace Mr. Wagner. Mr. Shapiro previously served as Chief Financial Officer of Livongo Health, Inc., a tech-enabled services company that helps individuals with chronic conditions to live better and healthier lives, until November 2020.
Clover has engaged a leading executive search firm to find a Chief Financial Officer for the next stage of the Company’s growth.
Vivek Garipalli, Clover Health’s Chief Executive Officer, said, “On behalf of Clover, I want to personally thank Joe for his hard work navigating the COVID-19 pandemic while simultaneously taking Clover public. We are entering an exciting phase of expansion as a public company and, following the recent appointments of a new Chief Growth Officer and Chief Strategy & Development Officer, we continue to develop our best-in-class management team to ensure we maximize our opportunities moving forward. I wish Joe and his family well.”
“Working with Vivek and Andrew to take Clover public has been a highlight of my career. I’ve done much thinking after weighing the health challenges related to a family member along with the demands of being the CFO of a public company. As a result, I’ve made the decision to seek a role with a privately held company closer to home which will allow me to devote more energy and attention to my family,” said Mr. Wagner. “I deeply believe in and support Clover’s focus on health equity and mission to improve every life. I will be watching and cheering along the way.”
Story continues
About Clover Health
Clover Health (Nasdaq: CLOV) is a next-generation risk-bearing organization aiming to achieve health equity for all Americans. While our mission is to improve every life, we particularly focus on seniors who have historically lacked access to affordable high quality healthcare.
We aim to provide great care, in a sustainable way, by having a business model built around improving medical outcomes while lowering avoidable costs. We do this while taking a holistic approach to understanding the health needs and social risk factors of those under our care. This strategy is underpinned by the company’s proprietary software platform, the Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making by providing physicians with real-time, personalized recommendations at the point of care.
Making care more accessible is at the heart of our business, and we believe patients should have the freedom to choose their doctors. We offer two models of care: affordable Medicare Advantage plans with extensive benefits; and care coordination for Original Medicare beneficiaries through Direct Contracting. For both programs, we provide primary care physicians with the Clover Assistant and also make comprehensive home-based care available via the Clover Home Care program.
With its corporate headquarters in Nashville, Clover’s workforce is distributed around the U.S. and also includes a team of world-class technologists based in Hong Kong. The company manages care for Medicare beneficiaries in eleven states, including Arizona, Georgia, Kansas, Mississippi, New Jersey, New York, Pennsylvania, South Carolina, Tennessee, Texas and Vermont.
Contacts:
Investor Relations:
Derrick Nueman
Press Contact:
Andrew Still-Baxter